BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24726367)

  • 1. Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformation.
    Maimon A; Mogilevsky M; Shilo A; Golan-Gerstl R; Obiedat A; Ben-Hur V; Lebenthal-Loinger I; Stein I; Reich R; Beenstock J; Zehorai E; Andersen CL; Thorsen K; Ørntoft TF; Davis RJ; Davidson B; Mu D; Karni R
    Cell Rep; 2014 Apr; 7(2):501-513. PubMed ID: 24726367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalanced splicing in MAPK signaling sustains Ras-induced transformation.
    Müller D; Martineau Y; Bousquet C; Pyronnet S
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):155-6. PubMed ID: 25468550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment.
    Mogilevsky M; Shimshon O; Kumar S; Mogilevsky A; Keshet E; Yavin E; Heyd F; Karni R
    Nucleic Acids Res; 2018 Nov; 46(21):11396-11404. PubMed ID: 30329087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization.
    Scheper GC; Parra JL; Wilson M; Van Kollenburg B; Vertegaal AC; Han ZG; Proud CG
    Mol Cell Biol; 2003 Aug; 23(16):5692-705. PubMed ID: 12897141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma.
    Liu H; Gong Z; Li K; Zhang Q; Xu Z; Xu Y
    J Exp Clin Cancer Res; 2021 Feb; 40(1):75. PubMed ID: 33602301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the human Mnk2 gene (MKNK2) through protein interaction with estrogen receptor beta.
    Slentz-Kesler K; Moore JT; Lombard M; Zhang J; Hollingsworth R; Weiner MP
    Genomics; 2000 Oct; 69(1):63-71. PubMed ID: 11013076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development.
    Ueda T; Watanabe-Fukunaga R; Fukuyama H; Nagata S; Fukunaga R
    Mol Cell Biol; 2004 Aug; 24(15):6539-49. PubMed ID: 15254222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRAK is essential for ras-induced senescence and tumor suppression.
    Sun P; Yoshizuka N; New L; Moser BA; Li Y; Liao R; Xie C; Chen J; Deng Q; Yamout M; Dong MQ; Frangou CG; Yates JR; Wright PE; Han J
    Cell; 2007 Jan; 128(2):295-308. PubMed ID: 17254968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells.
    Scheper GC; Morrice NA; Kleijn M; Proud CG
    Mol Cell Biol; 2001 Feb; 21(3):743-54. PubMed ID: 11154262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Drosophila protein kinase LK6 is regulated by ERK and phosphorylates the eukaryotic initiation factor eIF4E in vivo.
    Parra-Palau JL; Scheper GC; Harper DE; Proud CG
    Biochem J; 2005 Feb; 385(Pt 3):695-702. PubMed ID: 15487973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFβ1-mediated PI3K/Akt and p38 MAP kinase dependent alternative splicing of fibronectin extra domain A in human podocyte culture.
    Madne TH; Dockrell MEC
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):127-135. PubMed ID: 29729706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin enhances eIF4E phosphorylation by activating MAP kinase-interacting kinase 2a (Mnk2a).
    Stead RL; Proud CG
    FEBS Lett; 2013 Aug; 587(16):2623-8. PubMed ID: 23831578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2.
    Waskiewicz AJ; Flynn A; Proud CG; Cooper JA
    EMBO J; 1997 Apr; 16(8):1909-20. PubMed ID: 9155017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined inhibition of PI3K and activation of MAPK p38 signaling pathways trigger erythroid alternative splicing switch of 4.1R pre-mRNA in DMSO-induced erythroleukemia cells.
    Breig O; Théoleyre-Schaal O; Baklouti F
    Cell Signal; 2013 Dec; 25(12):2453-61. PubMed ID: 23993958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils.
    Nick JA; Avdi NJ; Young SK; Lehman LA; McDonald PP; Frasch SC; Billstrom MA; Henson PM; Johnson GL; Worthen GS
    J Clin Invest; 1999 Mar; 103(6):851-8. PubMed ID: 10079106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB inducing kinase activates NF-kappaB transcriptional activity independently of IkappaB kinase gamma through a p38 MAPK-dependent RelA phosphorylation pathway.
    Jijon H; Allard B; Jobin C
    Cell Signal; 2004 Sep; 16(9):1023-32. PubMed ID: 15212763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RSK activation via ERK modulates human colon cancer cells response to PTHrP.
    Calvo N; Carriere P; Martin MJ; Gentili C
    J Mol Endocrinol; 2017 Jul; 59(1):13-27. PubMed ID: 28385776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases).
    Buxade M; Parra-Palau JL; Proud CG
    Front Biosci; 2008 May; 13():5359-73. PubMed ID: 18508592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
    Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
    Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.